多支冠状动脉病变女性患者行冠状动脉旁路移植术与经皮冠状动脉介入治疗的比较
这项来自纽约州心脏登记处的回顾性倾向评分匹配队列研究(2012-2018年)纳入所有接受依维莫司洗脱支架(EES)经皮冠状动脉介入治疗(PCI)和冠状动脉旁路移植术(CABG)的多支冠状动脉病变女性患者。结果显示,与CABG相比,PCI与更高的6年全因死亡风险(25.75% vs 23.57%;AHR 1.29;95%CI 1.14-1.45)及主要不良心脏事件复合终点风险相关。但在PCI患者实现完全血运重建、非复杂病变或无糖尿病的女性中,两种干预的死亡率无差异。
要点
- 多支冠状动脉病变女性中,PCI与EES较CABG的6年全因死亡风险更高(25.75% vs 23.57%;AHR 1.29;95%CI 1.14-1.45)。
- PCI组死亡、心肌梗死和卒中复合终点发生率更高(36.58% vs 32.89%;AHR 1.28;95%CI 1.17-1.41)。
- PCI组重复血运重建率更高(21.53% vs 11.57%;AHR 1.88;95%CI 1.63-2.17);完全血运重建、非复杂病变或无糖尿病的女性中两种干预死亡率无差异。
核心结论
- 对于多支冠状动脉病变女性,与PCI with EES相比,CABG与更低的6年死亡率、心肌梗死和重复血运重建率相关。
研究设计与样本
- 回顾性、倾向评分匹配队列研究,来自纽约州心脏登记处(2012-2018年),纳入所有接受PCI with EES和CABG的多支冠状动脉病变女性。
主要发现
- PCI with EES与更高的6年死亡风险相关(25.75% vs 23.57%;AHR 1.29;95%CI 1.14-1.45)。
- PCI与更高的死亡、心肌梗死和卒中复合终点发生率相关(36.58% vs 32.89%;AHR 1.28;95%CI 1.17-1.41)。
- PCI与更高的心肌梗死发生率相关(14.94% vs 9.12%;AHR 1.84;95%CI 1.56-2.17),但卒中无差异(7.07% vs 7.62%;AHR 0.83;95%CI 0.67-1.03)。
- PCI组重复血运重建率更高(21.53% vs 11.57%;AHR 1.88;95%CI 1.63-2.17)。
- 在PCI患者实现完全血运重建、非复杂病变或无糖尿病的女性中,两种干预的死亡率无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare outcomes in women undergoing percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) surgery. DESIGN: This retrospective, propensity-score matched cohort study from the New York State cardiac registry (2012-2018) included all women with multivessel coronary artery disease undergoing PCI with everolimus-eluting stents (EES) and CABG surgery. The primary outcome was all-cause mortality. The key secondary outcome was major adverse cardiac events, defined as the composite of all-cause mortality, myocardial infarction, and stroke. RESULTS: PCI with EES was associated with a higher 6-year risk of mortality (25.75% vs 23.57%; adjusted hazard ratio [AHR], 1.29; 95% confidence interval [CI], 1.14-1.45). PCI also was associated with a higher rate of the composite outcome of death, myocardial infarction, and stroke (36.58% vs 32.89%; AHR, 1.28; 95% CI, 1.17-1.41), as well as myocardial infarction (14.94% vs 9.12%; AHR, 1.84; 95% CI, 1.56-2.17), but not stroke (7.07% vs 7.62%; AHR, 0.83; 95% CI, 0.67-1.03). Repeat revascularization rates also were higher for women undergoing PCI (21.53% vs 11.57%; AHR, 1.88; 95% CI, 1.63-2.17). There was no difference in mortality between the 2 interventions when PCI patients received complete revascularization or had noncomplex lesions and for women without diabetes. CONCLUSIONS: For women with multivessel coronary artery disease, CABG surgery is associated with lower 6-year mortality, myocardial infarction, and repeat revascularization rates compared to PCI with EES.
引用
- Hannan EL, Wu Y, Harik L, et al. Coronary artery bypass surgery versus percutaneous interventions for women with multivessel coronary artery disease. J Thorac Cardiovasc Surg. 2023. PMID: 38101766. doi:10.1016/j.jtcvs.2023.12.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。